Health
Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients – News-Medical.Net
However, a fascinating new study posted to the medRxiv* preprint server suggests that such disappointment may have been both premature and unwarranted, based on…
Treatment options have been limited in the ongoing coronavirus disease 2019 (COVID-19) pandemic. Earlier optimism regarding immunomodulatory drugs such as azithromycin (AZM) and hydroxychloroquine (HCQ) seemed to be undermined by results of large interventional trials.
However, a fascinating new study posted to the medRxiv* preprint server (not peer-reviewed*)
, suggests that such disappointment may have been both premature and unwarranted, based on a re-analysis of over 250 patients on invasive…
-
Business24 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%
-
General23 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General16 hours agoPhotographers reveal iconic image of Gough Whitlam and Vincent Lingiari was posed on Wave Hill Walk-Off anniversary
-
Noosa News14 hours agoDog daycare program a TikTok hit for helping disabled find work, friends